Skip to main content
Erschienen in: Rheumatology International 2/2017

20.12.2016 | Observational Research

The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study

verfasst von: Yan Liang, Rui-Xue Leng, Hai-Feng Pan, Dong-Qing Ye

Erschienen in: Rheumatology International | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

This study aims to estimate the prevalence of serositis and identify risk factors for serositis in a large cohort of systemic lupus erythematosus (SLE) patients. A cross-sectional study was conducted based on the medical records of patients hospitalized with SLE at the First Affiliated Hospital of Anhui Medical University and Anhui Provincial Hospital. Patients were diagnosed with serositis when they presented with symptoms and signs of pleuritis or/and pericarditis. We explored factors associated with the generation and quantity of serositis by using binary and ordinal logistic regression analysis. Among the 1668 lupus patients, 298 have serositis. Active lupus disease, fever (≥38 °C) and high D-dimer were all significantly associated with the generation and quantity of serositis. Male gender was independent significant risk factor for pleuritis but not for pericarditis, while low complement C4 and high erythrocyte sedimentation rate (ESR) were risk factors for pericarditis rather than for pleuritis. The possible prevalence of serositis in patients with SLE was 17.9%. The significant associations of active lupus disease, fever (≥38 °C) and high D-dimer with serositis suggest that higher disease activity and hypercoagulability may both contribute to the generation and development of serositis in SLE. The risk factors for pleuritis and pericarditis in SLE are similar but not identical.
Literatur
1.
Zurück zum Zitat Liang Y, Xu WD, Peng H, Pan HF, Ye DQ (2014) SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications. Eur J Immunol 44:1265–1275CrossRefPubMed Liang Y, Xu WD, Peng H, Pan HF, Ye DQ (2014) SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications. Eur J Immunol 44:1265–1275CrossRefPubMed
2.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed
3.
Zurück zum Zitat Crozier IG, Li E, Milne MJ, Nicholls MG (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65:1145–1148CrossRefPubMed Crozier IG, Li E, Milne MJ, Nicholls MG (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65:1145–1148CrossRefPubMed
4.
Zurück zum Zitat Zhao J, Bai W, Zhu P et al (2016) Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus. Lupus 25:652–657CrossRefPubMed Zhao J, Bai W, Zhu P et al (2016) Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus. Lupus 25:652–657CrossRefPubMed
5.
6.
Zurück zum Zitat Weich HS, Burgess LJ, Reuter H, Brice EA, Doubell AF (2005) Large pericardial effusions due to systemic lupus erythematosus: a report of eight cases. Lupus 14:450–457CrossRefPubMed Weich HS, Burgess LJ, Reuter H, Brice EA, Doubell AF (2005) Large pericardial effusions due to systemic lupus erythematosus: a report of eight cases. Lupus 14:450–457CrossRefPubMed
7.
Zurück zum Zitat Clarke A (2004) Proposed modifications to 1982 ACR classification criteria for systemic lupus erythematosus: serositis criterion. Lupus 13:855–856CrossRefPubMed Clarke A (2004) Proposed modifications to 1982 ACR classification criteria for systemic lupus erythematosus: serositis criterion. Lupus 13:855–856CrossRefPubMed
8.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed
9.
Zurück zum Zitat Man BL, Mok CC (2005) Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 14:822–826CrossRefPubMed Man BL, Mok CC (2005) Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus 14:822–826CrossRefPubMed
10.
Zurück zum Zitat Ngandeu MS, Ndobo P, Gabay C (2009) Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaoundé-Cameroon. Clin Rheumatol 28:465–468CrossRefPubMed Ngandeu MS, Ndobo P, Gabay C (2009) Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaoundé-Cameroon. Clin Rheumatol 28:465–468CrossRefPubMed
11.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed
12.
Zurück zum Zitat Li LH, Pan HF, Li WX, Li XP, Xu JH, Ye DQ (2009) Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population. Clin Rheumatol 28:1301–1307CrossRefPubMed Li LH, Pan HF, Li WX, Li XP, Xu JH, Ye DQ (2009) Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population. Clin Rheumatol 28:1301–1307CrossRefPubMed
13.
Zurück zum Zitat Glauser FL, Otis PT, Levine RI, Smith WR (1976) Coagulation factors and fibrinogen in pleural effusions. Respiration 33:396–402CrossRefPubMed Glauser FL, Otis PT, Levine RI, Smith WR (1976) Coagulation factors and fibrinogen in pleural effusions. Respiration 33:396–402CrossRefPubMed
14.
Zurück zum Zitat Strange C, Baumann MH, Sahn S, Idell S (1995) Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Crit Care Med 151:508–515CrossRef Strange C, Baumann MH, Sahn S, Idell S (1995) Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease. Am J Crit Care Med 151:508–515CrossRef
15.
Zurück zum Zitat Idell S, Girard W, Koenig K, McLarty J, Fair DS (1991) Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 144:187–194CrossRefPubMed Idell S, Girard W, Koenig K, McLarty J, Fair DS (1991) Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 144:187–194CrossRefPubMed
16.
Zurück zum Zitat Tillet WS, Sherry S, Read CT (1951) Use of streptokinase-streptodornase in treatment of postpneumonic empyema. J Thorac Surg 21:275–297 Tillet WS, Sherry S, Read CT (1951) Use of streptokinase-streptodornase in treatment of postpneumonic empyema. J Thorac Surg 21:275–297
17.
Zurück zum Zitat Petelin A, Johnson DH, Cunha BA (2013) Fever of unknown origin (FUO) due to systemic lupus erythematosus (SLE) presenting as pericarditis. Heart Lung 42:152–153CrossRefPubMed Petelin A, Johnson DH, Cunha BA (2013) Fever of unknown origin (FUO) due to systemic lupus erythematosus (SLE) presenting as pericarditis. Heart Lung 42:152–153CrossRefPubMed
Metadaten
Titel
The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study
verfasst von
Yan Liang
Rui-Xue Leng
Hai-Feng Pan
Dong-Qing Ye
Publikationsdatum
20.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 2/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3630-0

Weitere Artikel der Ausgabe 2/2017

Rheumatology International 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.